GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)
Clinical trial NCT01497665 · TERMINATED
Trial details
- NCT number
- NCT01497665
- Sponsor
- Angiochem Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-01-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.